Search results
Contact Us. AbbVie Pte Ltd (Regional & Commercial Operations) 9 North Buona Vista Drive #19-01. The Metropolis Tower One. Singapore 138588. Tel: +65 6715 8100. AbbVie Operations Singapore Pte Ltd (Manufacturing Operations) 23 Tuas South Avenue 6. Singapore 637022.
Jan 25, 2024 · This new investment will add more than 100 jobs and new biologics manufacturing capacity to AbbVie's global network. Located in Singapore's Tuas Biomedical Park, AbbVie's Singapore plant is a state-of-the-art small-molecule and biologics manufacturing facility serving markets worldwide.
Finding Better Solutions to the Toughest Challenges. Research and innovation are the cornerstones of our business. We focus on discovering, developing and delivering drugs in therapeutic areas where we have proven expertise—and can make an impact. This includes Immunology, Oncology, Neuroscience and Virology.
Our approach to innovation builds on strong science combined with the drive to find solutions where the need is the greatest. Our science. If we bring a new medicine to market, it can help patients worldwide, as opposed to the 20 or so patients we might see in clinic in one day.
Nov 21, 2014 · Reflecting progress from AbbVie's announcement for manufacturing investment in Asia earlier this year, AbbVie Inc. has acquired a small molecule active pharmaceutical ingredient (API) manufacturing site in Singapore's Tuas Biomedical Park.
Located in Singapore's Tuas Biomedical Park, AbbVie's Singapore plant is a state-of-the-art small-molecule and biologics manufacturing facility serving markets worldwide.
Jan 30, 2024 · AbbVie, a US pharmaceutical company, is investing $223 million in expanding its manufacturing facility in Singapore’s Tuas Biomedical Park. This expansion is expected to create over 100 jobs and increase biologics manufacturing capacity by 24,000 liters.
Sep 29, 2016 · AbbVie in 2014 announced its plans to build the 120,000-square-meter (1.2 million-square-foot) site in the Tuas Biomedical Park in Singapore, its first facility in Asia.
5 days ago · Construction of the new plant at Singapore’s Tuas Biomedical Park is now underway and, when completed, will add 24,000 litres of biologics drug-substance capacity to AbbVie’s global...
AbbVie
